Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?

dc.authoridSARICI, Ahmet/0000-0002-5916-0119
dc.authoridTanriverdi, Lokman Hekim/0000-0003-4263-5234
dc.authorwosidSARICI, Ahmet/ABI-7512-2020
dc.authorwosidTanriverdi, Lokman Hekim/M-5701-2015
dc.contributor.authorSarici, Ahmet
dc.contributor.authorTanriverdi, Lokman Hekim
dc.date.accessioned2024-08-04T20:59:47Z
dc.date.available2024-08-04T20:59:47Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS384en_US
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.startpageS384en_US
dc.identifier.urihttps://hdl.handle.net/11616/103513
dc.identifier.volume23en_US
dc.identifier.wosWOS:001062479600355en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherCig Media Group, Lpen_US
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemiaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMPNen_US
dc.subjectferric carboxymaltoseen_US
dc.subjectFCMen_US
dc.subjectiron deficiency anemiaen_US
dc.subjectIDAen_US
dc.titleIs Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?en_US
dc.typeConference Objecten_US

Dosyalar